Today: 9 June 2026
Firefly Aerospace stock slides 10% as FLY lock-up deadline hits Tuesday
2 February 2026
1 min read

Firefly Aerospace stock slides 10% as FLY lock-up deadline hits Tuesday

NEW YORK, Feb 2, 2026, 15:20 (ET) — Regular session

  • Shares of Firefly Aerospace dropped roughly 10%, settling at $22.62 in the afternoon session
  • A post-IPO lock-up ends on Feb. 3, which could free up a sizable block of shares for resale
  • Traders are eyeing insider sales once the restriction lifts, along with a February 7 lock-up related to an acquisition

Shares of Firefly Aerospace Inc dipped in Monday afternoon trading, dropping $2.58, or 10.2%, to $22.62. Investors appear wary ahead of the upcoming post-IPO share lock-up expiration. The stock fluctuated between $22.35 and $25.37 during the session, with roughly 3.5 million shares exchanged.

Timing is crucial here since lock-ups prevent insiders and early investors from offloading shares for a set period post-IPO, tightening supply. Once that window closes, the volume of shares available to trade often jumps, occasionally quite suddenly.

A company prospectus revealed that about 125.9 million shares could become eligible for sale after the lock-up ends on Feb. 3, though U.S. securities rules impose certain limits. Firefly, along with its officers, directors, and major shareholders—including AE Industrial Partners—have agreed not to sell shares from Aug. 6, 2025, through Feb. 3, 2026, without the underwriters’ permission. The filing also noted a separate restriction on shares acquired through an acquisition, which extends until Feb. 7, 2026.

The decline happened while the broader market stayed firm. The S&P 500 gained roughly 0.3% on the day, per Reuters market data.

Firefly, the company behind launch vehicles and lunar landers, pulled in $868.3 million from an upsized Nasdaq IPO priced at $45 a share this August. Since then, the stock has dropped about 50% from its debut price.

Shares of other space-related companies dropped as well. Redwire slipped roughly 6%, AST SpaceMobile lost about 5.5%, and Intuitive Machines declined close to 6% in afternoon trading.

That said, the end of the lock-up period won’t automatically trigger a flood of sales. Some shareholders might hold steady, and insiders are restricted in how much they can offload within short timeframes, based on their roles and the stock’s trading status.

The risk for bulls is clear: if sellers flood the market as restrictions ease, the surge in supply might overwhelm demand and drag the stock down, particularly given its low trading volume. Even a small operational hiccup — whether a postponed launch, a mission glitch, or a lost contract — could quickly sour sentiment in this niche sector.

Investors have their eyes on Tuesday, Feb. 3, expecting stock to hit the tape following the lock-up expiry, along with any insider sales that might be disclosed. Then there’s the Feb. 7 deadline, connected to shares issued as part of the acquisition.

Stock Market Today

  • Hexagon Nutrition IPO Oversubscribed by 54x; NLC OFS and NSE CSR Initiative Highlight Market Activity
    June 9, 2026, 10:07 AM EDT. Hexagon Nutrition's initial public offering (IPO) drew robust interest, oversubscribed 54 times, signaling strong investor demand. Meanwhile, NLC India's Offer for Sale (OFS) also exceeded subscription targets. In parallel, the National Stock Exchange (NSE) announced a commitment to corporate social responsibility (CSR) efforts through support for the Social Stock Exchange, marking a notable blend of market activity and social initiatives.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
XPeng stock sinks on January delivery update as China EV demand jitters hit sector
Previous Story

XPeng stock sinks on January delivery update as China EV demand jitters hit sector

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Next Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

Go toTop